Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.19 USD
-0.09 (-7.03%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $1.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.59 |
EPS Last Quarter | -0.68 |
Last EPS Surprise | 0.00% |
ABR | 1.55 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.87 |
Next Year | -0.90 |
EPS (TTM) | -2.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.05M | 9.92M | 39.42M | 61.54M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 11.70M | 11.90M | 53.40M | 89.90M |
Low Estimate | 7.92M | 8.67M | 34.01M | 44.80M |
Year ago Sales | 6.08M | 7.34M | 30.99M | 39.42M |
Year over Year Growth Est. | 48.91% | 35.20% | 27.21% | 56.11% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.59 | -0.42 | -1.87 | -0.90 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -0.58 | -0.37 | -1.82 | -0.99 |
High Estimate | -0.54 | -0.37 | -1.44 | -0.59 |
Low Estimate | -0.68 | -0.49 | -2.14 | -1.50 |
Year ago EPS | -0.61 | -0.61 | -2.63 | -1.87 |
Year over Year Growth Est. | 3.28% | 31.15% | 28.90% | 51.73% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 6 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.59 | -0.42 | -1.87 | -0.90 |
7 Days Ago | -0.59 | -0.42 | -1.87 | -0.90 |
30 Days Ago | -0.59 | -0.42 | -1.87 | -0.90 |
60 Days Ago | -0.60 | -0.55 | -2.23 | -1.14 |
90 Days Ago | -0.59 | -0.58 | -2.43 | -1.97 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.59 | -0.42 | -1.87 | -0.69 |
Zacks Consensus Estimate | -0.59 | -0.42 | -1.87 | -0.90 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 23.46% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.68 | -0.74 | -0.61 | -0.61 | NA |
Estimate | -0.68 | -0.64 | -0.67 | -0.76 | NA |
Difference | 0.00 | -0.10 | 0.06 | 0.15 | 0.03 |
Surprise | 0.00% | -15.63% | 8.96% | 19.74% | 3.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more